live Feed:
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply - Catalent's Indiana plant to make Novo's Wegovy weight-loss drug

Catalent

22 days ago
bookmarkBookmark

Key facts

Classified as: organization

Summary

Catalent is a company. It is located in San Diego, the United States and was founded in 1999. The company is part of the Health Care sector, specifically in the Pharmaceuticals industry.

Business

  • Employees: get premium Premium to see estimate
  • Revenues: get premium Premium to see estimate

Stocks from Catalent

Explore more on business

Talking Points:

  • San Diego, USA
  • Catalent’s San Diego facility focuses on early stage development of small molecule and peptide drug candidates from the bench to the clinic.
  • From drug and biologic development services to delivery technologies to supply solutions. Catalent. More products. Better treatments. Reliably supplied.™
  • Pharmatek Laboratories, Inc. is a premier pharmaceutical chemistry development and manufacturing organization supporting the pharmaceutical and ...
Learn more about talking points

In literature

There is no book written about Catalent in the database

Related

Connected or similar:

Details

This dashboard is based on data from: YAHOO-FIN, YFINANCE, Twitter

This content can be used under the CC BY 4.0 license